MBX Biosciences (MBX) Treasury Shares (2023 - 2024)

MBX Biosciences has reported Treasury Shares for 4 years, with the latest figure at $163562.0 in Q1 2026.

• Quarterly Treasury Shares rose 1908.13% year-over-year to $163562.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163562.0 (up 1908.13% YoY) and the FY2025 annual result came in at $694.0, down 94.5% from the prior year.
• Treasury Shares rose to $163562.0 in Q1 2026 per MBX's latest filing, from $2514.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $129.2 million in Q3 2023 and troughed at $2514.0 in Q3 2025.
• A 4-year average of $51.7 million and a median of $90800.5 in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares plunged 100.0% in 2025, then soared 1908.13% in 2026.
• Over 4 years, Treasury Shares stood at $129.2 million in 2023, then plunged by 99.99% to $12608.0 in 2024, then plunged by 80.06% to $2514.0 in 2025, then surged by 6406.05% to $163562.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $163562.0, $2514.0, and $5077.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.